📢The official Ourlyard® flagship store: products are patented. Counterfeiting will be prosecuted.

The supramolecular collaborative drug delivery method used in Ourlyard® Eye Drops isn’t just clever—it’s the result of years of rigorous research by multiple experts and scholars across the fields of ophthalmology, chemistry, and molecular medicine. It’s supported by peer-reviewed publications.

And this isn’t just theory—it’s innovation that has been recognized. In 2023, this very technology received the Edison Silver Award, a mark of excellence in applied science and innovation.

According to Dr. James Lenzberger‘s research, supramolecular composite drug delivery technology has been proven to effectively enhance the stability, permeability, and targeting of ocular drugs. This technology has been extensively researched and validated by numerous experts and scholars, and has shown significant results in clinical applications. By precisely controlling the release of drug molecules, supramolecular eye drops can improve the efficacy of ocular medications, providing more efficient and sustained therapeutic effects.

Our eye drops have undergone clinical testing by ophthalmology experts and have been proven to significantly improve eye health within 1-3 weeks, relieve discomfort, enhance ocular comfort, and show results within 2-7 days.

Let’s take a look at what makes the Ourlyard® Supramolecular Eye Drops so special.

Ourlyard® Supramolecular Eye Drops utilizes advanced supramolecular composite technology. By applying the principle of non-covalent self-assembly, various active ingredients are encapsulated into a nanoscale supramolecular network, ensuring precise delivery to the targeted areas of the eye. This significantly enhances the stability, permeability, and bioavailability of the medication.

This composite technology allows for sustained release after the drug enters the eye, effectively penetrating the corneal and conjunctival barriers. It reduces drug loss, decreases usage frequency, and enhances therapeutic effects.

The supramolecular composite structure closely adheres to the corneal surface, helping restore the elasticity and shape of the lens, improving the nutritional supply to eye cells, and promoting the elimination of metabolic waste, thus enhancing overall eye health. Additionally, it has a short-term pupil regulation function, which helps improve near-distance clarity while maintaining good long-distance vision.

Let’s take a look at real reviews from users after using the product

👇👇👇👇👇👇👇👇

“I developed cataracts in one eye, and it’s been progressing for about five or six years. Although I’ve been waiting for surgery, I’ve always felt hesitant about having my lens removed. Then I came across Ourlyard® Eye Drops online, and to my surprise, after just two weeks of use, I noticed a significant improvement in my vision—the blurry feeling I used to wake up with had started to fade.

Now, after two months, my vision has improved noticeably. I can comfortably use my phone again, and even drive with confidence. I’m truly grateful for Ourlyard®—it has helped me regain clarity and freedom in my daily life.”—James Anderson

“I started seeing these little black dots and stringy floaters in my vision sometime last year—especially when I looked at bright backgrounds like the sky or a white wall. My eye doctor said it was just floaters, but honestly, it really got on my nerves. It made it hard to focus, and sometimes my vision felt totally off.

I came across this eye drop online with a bunch of good reviews and figured, why not give it a shot? I’ve been using it every day, and by the third week or so, I actually started noticing a difference. The floaters weren’t as bad, and my eyes didn’t feel as dry either.

Now it’s been almost two months, and my floaters are completely gone. My vision feels much clearer.”—Robert Walker

“I have retinopathy and have been getting eye injections every 8 weeks. I’ve had 13 so far, and the doctor said I might need them for the rest of my life. But ever since I started using Ourlyard® Eye Drops daily, things changed. After two months, I went in for a check-up, and the doctor said my eyes looked great—no fluid leakage at all. For the first time ever, I didn’t need another injection. I’m truly grateful for Ourlyard®. It’s given me real hope.”— Mark Reynolds

”I have suffered from severe dry eyes for 25 years and tried many different eye drops, but almost none worked. Each time I applied them, relief lasted only a few seconds to maybe a minute; the drops just wouldn’t stay, and my eyes kept hurting. I couldn’t even watch TV during the day, and on cloudy or rainy days, I had to wear sunglasses because my eyes were so sensitive. I even had to quit my job as a truck driver because of this.

After a friend recommended Ourlyard® Eye Drops, I gave them a try. Just a few days later, my eyes felt much better. Unlike other drops, Ourlyard® provides long-lasting relief and reduces light sensitivity during the day.

If you’ve struggled with dry eyes for years like me, I truly recommend Ourlyard®. It’s unlike anything else I’ve tried.“— David Thompson

What can our eye drops offer you?

Understanding Common Eye Diseases：

Presbyopia usually occurs around the age of 40. As the lens inside the eye gradually loses its elasticity and focusing ability, near vision declines. Presbyopia affects daily life, especially when reading or using a computer. Ourlyard® Eye Drops can penetrate the eye, help restore the lens’s elasticity, and improve near vision. After use, you’ll find daily tasks like reading and using a computer much easier, with clearer vision.

Cataracts are one of the most common eye diseases among the elderly, usually occurring when the eye’s transparent structure—the lens—becomes cloudy, causing vision to gradually blur or become hazy. The formation of cataracts is typically caused by aging, UV exposure, and diabetes. Cataracts are a progressive disease but reversible. Ourlyard® Eye Drops uses advanced supramolecular technology to effectively target the lens, disassemble the cloudy aggregates at the molecular level, and temporarily restore its transparency, thereby improving vision.

Glaucoma is a condition caused by increased intraocular pressure, leading to damage of the optic nerve. It often has no noticeable symptoms in the early stages, so many patients don’t realize the problem until their vision begins to deteriorate.

Ourlyard® Eye Drops employs advanced supramolecular composite technology, which enhances the regulation of fluid dynamics within the eye by promoting efficient drainage and effectively lowering intraocular pressure. The supramolecular composites enable controlled and sustained release of active ingredients like L-carnitine, helping to slow the progression of glaucoma. This offers patients a safe, non-invasive, and highly effective treatment option.

Dry Eye Syndrome is an eye condition caused by insufficient tear production or an unstable tear film, commonly presenting as dry eyes, foreign body sensation, stinging, and sensitivity to wind. As we age, the function of the tear glands gradually weakens. If left untreated, the symptoms of dry eye syndrome may lead to corneal damage and affect vision. Our eye drops not only provide immediate relief from dry eye symptoms but also maintain long-lasting lubrication, help stabilize the tear film, and alleviate discomfort, leaving your eyes feeling more comfortable.

Diabetic retinopathy is a common eye complication in diabetic patients, caused by prolonged high blood sugar that damages the retinal microvessels, leading to leakage, bleeding, or the formation of new blood vessels. In severe cases, it can result in vision loss. After 5 years of diabetes, the condition enters a high-risk stage, and 70% of type 2 diabetes patients may lose their vision. Ourlyard® Eye Drops employs advanced supramolecular composite technology, overcoming the challenge of traditional eye drops being unable to effectively deliver drugs to the posterior eye tissues. It can penetrate deeply into the retina to effectively reduce retinal swelling, constrict blood vessels, and stop leakage. This helps restore vision, slow the progression of diabetic retinopathy, and reduce the risk of vision loss.

Floaters are a common phenomenon in the eyes, appearing as small dark spots, lines, or cobweb-like shapes that drift across your field of vision—like tiny insects flying in front of your eyes. They’re especially noticeable when looking at bright backgrounds such as a white wall or the sky, and are typically caused by mild clouding in the vitreous humor of the eye. Our eye drops can help relieve and improve this condition.

💧How Does Ourlyard® Supramolecular Eye Drops  Work?

Ourlyard® primarily works by restoring lens elasticity, improving cellular nutrition in the eyes, and clearing accumulated cellular debris.

Ourlyard® utilizes advanced supramolecular technology, in which active ingredients are stably encapsulated within supramolecular carrier structures through non-covalent interactions such as hydrogen bonding, electrostatic forces, and hydrophobic effects. These structures can efficiently penetrate the corneal barrier and reach deep ocular tissues. Compared to traditional carriers, supramolecular systems can respond to local ocular conditions—such as changes in pH or temperature—enabling targeted, on-demand drug release to affected areas and enhancing therapeutic efficacy.

Additionally, Ourlyard® features a precisely balanced pH formula that matches the natural tear film, providing long-lasting hydration, relieving dryness, and forming a protective barrier for the eyes.

This technology significantly enhances the drug’s stability, penetration, and targeting ability within the eye, allowing it to reach deep into the posterior segment to reduce intraocular pressure, restore lens elasticity, and repair retinal tissue. The formula is gentle, pH-balanced with the tear film, making it safe for long-term use and non-irritating.

Multiple active ingredients:

Spirulina：Spirulina is rich in high concentrations of zeaxanthin, which is primarily concentrated in the central area of the macula, the part of the eye responsible for sharp vision. Zeaxanthin plays a key role in filtering blue light and UV rays, helping to protect against photo-oxidative damage. As we age, the macula becomes more susceptible to damage from blue light and UV exposure, leading to issues such as blurry vision, cataracts, or macular degeneration. Supplementing with zeaxanthin helps slow visual aging and protect the structure of the macula.

N-Acetylcysteine:  (NAC) promotes the production of glutathione, which helps protect the retina and nerve cells by inhibiting oxidative stress. This is particularly important for glaucoma patients, as their optic nerves may be damaged. NAC activates adult stem cells, supporting the natural repair and regeneration of damaged eye tissues, including the retina, optic nerve, and lens.

Pirenzepine : Pirenzepine is a key ingredient in the treatment of myopia, working by inhibiting excessive contraction of the eye muscles, which slows the overgrowth of the eyeball. This helps control the progression of myopia and prevents the shape of the eyeball from changing further. Long-term use of this ingredient can effectively slow the worsening of myopia.

Resveratrol：Resveratrol is a natural polyphenolic compound that is beneficial for the microcirculation of the eye, helping to prevent ocular diseases such as age-related macular degeneration, diabetic retinopathy, and glaucoma. Studies have shown that resveratrol has antioxidant, anti-apoptotic, anti-tumor, anti-inflammatory, anti-angiogenic, and vasorelaxant properties.

Brimonidine: Brimonidine is a potent ingredient used in eye drops, particularly effective for treating dry eye syndrome. It works by reducing the dilation of blood vessels in the eye, thereby alleviating eye redness and discomfort. Brimonidine also helps reduce excessive dryness and irritation, keeping the eyes moist and improving dry eye symptoms. It is especially beneficial for relieving dryness caused by prolonged use of electronic devices or extended exposure to air-conditioned environments.